drugset / Trial / NCT00090376

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

NCT00090376

RandomizedParallel-groupDouble-blindTreatment

Summary

In this phase II study, an investigative (not approved by the FDA) drug called GPI 1485 is being assessed to see if it can help preserve erectile function after prostatectomy.

Timeline

Start
2003-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject GPI 1485 Small molecule Oral